冠状动脉旁路移植术后心脏康复专家共识

2020-02-10 国家心血管病中心 中国循环杂志.2020.35(1):4-15.

冠状动脉旁路移植术( CABG)是治疗冠心病常见的血运重建手段。CABG 后心脏康复是一项综合的、整体的全程医疗管理模式,包括运动治疗、二级预防用药、营养支持、心理管理、戒烟等方面,CABG 后规范的心脏康复对于降低再住院率,提高患者运动能力和生活质量以及预防心血管不良事件等方面具有积极意义。因此,为了促进我国CABG 后心脏康复的规范化发展,国家心血管病中心、CABG 后心脏康复专家共识编写委员

中文标题:

冠状动脉旁路移植术后心脏康复专家共识

发布机构:

国家心血管病中心

发布日期:

2020-02-10

简要介绍:

冠状动脉旁路移植术( CABG)是治疗冠心病常见的血运重建手段。CABG 后心脏康复是一项综合的、整体的全程医疗管理模式,包括运动治疗、二级预防用药、营养支持、心理管理、戒烟等方面,CABG 后规范的心脏康复对于降低再住院率,提高患者运动能力和生活质量以及预防心血管不良事件等方面具有积极意义。因此,为了促进我国CABG 后心脏康复的规范化发展,国家心血管病中心、CABG 后心脏康复专家共识编写委员会在2016 年《中西医结合冠状动脉旁路移植术Ⅰ期心脏康复专家共识》的基础上,就CABG 后心脏康复相关问题进行深入探讨,制定了我国CABG 后心脏康复专家共识。其中,针对CABG 后心脏康复的术前评估、围术期营养、早期营养支持、重症监护病房(ICU)期间康复、社会心理因素干预、睡眠管理等重要问题提出了明确建议。

 

拓展指南:心脏相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=冠状动脉旁路移植术后心脏康复专家共识)] GetToolGuiderByIdResponse(projectId=1, id=a2e431c00186a80a, title=冠状动脉旁路移植术后心脏康复专家共识, enTitle=, guiderFrom=中国循环杂志.2020.35(1):4-15., authorId=null, author=, summary=冠状动脉旁路移植术( CABG)是治疗冠心病常见的血运重建手段。CABG 后心脏康复是一项综合的、整体的全程医疗管理模式,包括运动治疗、二级预防用药、营养支持、心理管理、戒烟等方面,CABG 后规范的心脏康复对于降低再住院率,提高患者运动能力和生活质量以及预防心血管不良事件等方面具有积极意义。因此,为了促进我国CABG 后心脏康复的规范化发展,国家心血管病中心、CABG 后心脏康复专家共识编写委员, cover=, journalId=null, articlesId=null, associationId=1878, associationName=国家心血管病中心, associationIntro=, copyright=0, guiderPublishedTime=Mon Feb 10 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>冠状动脉旁路移植术( CABG)是治疗冠心病常见的血运重建手段。CABG 后心脏康复是一项综合的、整体的全程医疗管理模式,包括运动治疗、二级预防用药、营养支持、心理管理、戒烟等方面,CABG 后规范的心脏康复对于降低再住院率,提高患者运动能力和生活质量以及预防心血管不良事件等方面具有积极意义。因此,为了促进我国CABG 后心脏康复的规范化发展,国家心血管病中心、CABG 后心脏康复专家共识编写委员会在2016 年《中西医结合冠状动脉旁路移植术Ⅰ期心脏康复专家共识》的基础上,就CABG 后心脏康复相关问题进行深入探讨,制定了我国CABG 后心脏康复专家共识。其中,针对CABG 后心脏康复的术前评估、围术期营养、早期营养支持、重症监护病房(ICU)期间康复、社会心理因素干预、睡眠管理等重要问题提出了明确建议。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>心脏</FONT>相关指南:</STRONG><BR> <UL> <LI><A title="2020 ESMO共识建议:癌症患者在肿瘤治疗过程中心脏病的管理" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=f65ba1c001863a0c">2020 ESMO共识建议:癌症患者在肿瘤治疗过程中心脏病的管理</A> <LI><A title=中国心脏康复与二级预防指南解读 target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=370651c00185e101">中国心脏康复与二级预防指南解读</A> <LI><A title=2019年欧洲加速康复外科协会《心脏手术围术期监护指南》解读 target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=eb2bd1c0018569cd">2019年欧洲加速康复外科协会《心脏手术围术期监护指南》解读</A> <LI><A title=心脏骤停复苏后血流动力学管理的专家共识 target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=729231c0018a85cc">心脏骤停复苏后血流动力学管理的专家共识</A> <LI><A title=心脏骤停基层诊疗指南(实践版·2019) target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=00a981c0018a266a">心脏骤停基层诊疗指南(实践版·2019)</A> 更多信息请点击:<A target=_blank href="https://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%84%8F">有关心脏更多指南</A></LI></UL>, tagList=[TagDto(tagId=2769, tagName=冠状动脉旁路移植术), TagDto(tagId=8725, tagName=心脏康复)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8627, appHits=365, showAppHits=97, pcHits=3484, showPcHits=6203, likes=45, shares=35, comments=6, approvalStatus=1, publishedTime=Tue Feb 18 15:32:33 CST 2020, publishedTimeString=2020-02-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Feb 18 15:32:33 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 05:10:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=冠状动脉旁路移植术后心脏康复专家共识)])
冠状动脉旁路移植术后心脏康复专家共识
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1185036, encodeId=1a1b1185036a9, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:56 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185035, encodeId=ee01118503598, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:31 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185033, encodeId=38451185033e0, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:22 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003685, encodeId=24eb100368586, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/6f6883dbb0e24f0087875ef21cc0f282/62f7bae59f3e41cbacff5bc8d8f4ba1a.jpg, createdBy=cde45526117, createdName=Linxuezhang, createdTime=Thu Jul 29 21:33:30 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999249, encodeId=ae1599924998, content=正是我需要的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61c21449203, createdName=95246619, createdTime=Tue Jul 13 23:27:21 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2022-01-17 ms5000001966086883

    #心血管#学习到了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1185036, encodeId=1a1b1185036a9, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:56 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185035, encodeId=ee01118503598, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:31 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185033, encodeId=38451185033e0, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:22 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003685, encodeId=24eb100368586, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/6f6883dbb0e24f0087875ef21cc0f282/62f7bae59f3e41cbacff5bc8d8f4ba1a.jpg, createdBy=cde45526117, createdName=Linxuezhang, createdTime=Thu Jul 29 21:33:30 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999249, encodeId=ae1599924998, content=正是我需要的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61c21449203, createdName=95246619, createdTime=Tue Jul 13 23:27:21 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2022-01-17 ms5000001966086883

    学习啦

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1185036, encodeId=1a1b1185036a9, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:56 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185035, encodeId=ee01118503598, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:31 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185033, encodeId=38451185033e0, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:22 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003685, encodeId=24eb100368586, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/6f6883dbb0e24f0087875ef21cc0f282/62f7bae59f3e41cbacff5bc8d8f4ba1a.jpg, createdBy=cde45526117, createdName=Linxuezhang, createdTime=Thu Jul 29 21:33:30 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999249, encodeId=ae1599924998, content=正是我需要的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61c21449203, createdName=95246619, createdTime=Tue Jul 13 23:27:21 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2022-01-17 ms5000001966086883

    学习啦

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1185036, encodeId=1a1b1185036a9, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:56 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185035, encodeId=ee01118503598, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:31 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185033, encodeId=38451185033e0, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:22 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003685, encodeId=24eb100368586, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/6f6883dbb0e24f0087875ef21cc0f282/62f7bae59f3e41cbacff5bc8d8f4ba1a.jpg, createdBy=cde45526117, createdName=Linxuezhang, createdTime=Thu Jul 29 21:33:30 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999249, encodeId=ae1599924998, content=正是我需要的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61c21449203, createdName=95246619, createdTime=Tue Jul 13 23:27:21 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2021-07-29 Linxuezhang

    学到了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1185036, encodeId=1a1b1185036a9, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:56 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185035, encodeId=ee01118503598, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:31 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185033, encodeId=38451185033e0, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06465277, createdName=ms5000001966086883, createdTime=Mon Jan 17 00:56:22 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003685, encodeId=24eb100368586, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/6f6883dbb0e24f0087875ef21cc0f282/62f7bae59f3e41cbacff5bc8d8f4ba1a.jpg, createdBy=cde45526117, createdName=Linxuezhang, createdTime=Thu Jul 29 21:33:30 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999249, encodeId=ae1599924998, content=正是我需要的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61c21449203, createdName=95246619, createdTime=Tue Jul 13 23:27:21 CST 2021, time=2021-07-13, status=1, ipAttribution=)]
    2021-07-13 95246619

    正是我需要的文章

    0